You are here

J Clin Oncol DOI:10.1200/JCO.2012.46.8934

Genomics-driven oncology: framework for an emerging paradigm.

Publication TypeJournal Article
Year of Publication2013
AuthorsGarraway, LA
JournalJ Clin Oncol
Volume31
Issue15
Pages1806-14
Date Published2013 May 20
ISSN1527-7755
KeywordsChromosome Aberrations, Gene Regulatory Networks, Genetic Predisposition to Disease, Genomics, Humans, Medical Oncology, Models, Genetic, Mutation, Neoplasms
Abstract

A majority of cancers are driven by genomic alterations that dysregulate key oncogenic pathways influencing cell growth and survival. However, the ability to harness tumor genetic information for its full clinical potential has only recently become manifest. Over the past several years, the convergence of discovery, technology, and therapeutic development has created an unparalleled opportunity to test the hypothesis that systematic knowledge of genomic information from individual tumors can improve clinical outcomes for many patients with cancer. Rigorous evaluation of this genomics-driven cancer medicine hypothesis will require many logistic innovations that are guided by overarching conceptual advances in tumor genomic profiling, data interpretation, clinical trial design, and the ethical return of genetic results to oncologists and their patients. The results of these efforts and the rigor with which they are implemented will determine whether and how comprehensive tumor genomic information may become incorporated into the routine care of patients with cancer.

URLhttp://www.jco.org/cgi/pmidlookup?view=long&pmid=23589557
DOI10.1200/JCO.2012.46.8934
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/23589557?dopt=Abstract

Alternate JournalJ. Clin. Oncol.
PubMed ID23589557